List of Contributors

This book represents a collaborative effort with contributions from 42 scientists whose names are listed below.

Caroline Beunckens, Universiteit Hasselt

Bruno Boulanger, Eli Lilly

Carl-Fredrik Burman, AstraZeneca

John Castelloe, SAS Institute

Alan Chiang, Eli Lilly

Christy Chuang-Stein, Pfizer

Kimberly Crimin, Wyeth

Ralph D'Agostino, Boston University

Viswanath Devanaryan, Merck

Walthère Dewé, Eli Lilly

Alex Dmitrienko, Eli Lilly

Douglas Faries, Eli Lilly

Valerii Fedorov, GlaxoSmithKline

Kathleen Fritsch, Food and Drug Administration

Robert Gagnon, GlaxoSmithKline

Andy Grieve, Pfizer

Kevin Guo, Eli Lilly

Wherly Hoffman, Eli Lilly

Jason Hsu, The Ohio State University

Anastasia Ivanova, University of North Carolina

Ivy Jansen, Universiteit Hasselt

Kjell Johnson, Pfizer

Paul Juneau, Pfizer

Michael Kenward, London School of Hygiene and Tropical Medicine

Olga Kuznetsova, Merck

Cindy Lee, Eli Lilly

Sergei Leonov, GlaxoSmithKline

Geert Molenberghs, Universiteit Hasselt

Daniel Ness, Eli Lilly

Ralph O'Brien, Cleveland Clinic

Scott Patterson, GlaxoSmithKline

William Rayens, University of Kentucky

Stephen Ruberg, Eli Lilly

Stephen Senn, University of Glasgow

Brian Smith, Amgen

Wendell Smith, B2S Consulting

Herbert Thijs, Universiteit Hasselt

Kristel Van Steen, Universitiet Gent

Geert Verbeke, Katholieke Universiteit Leuven

Thomas Vidmar, Pfizer

Yuehui Wu, GlaxoSmithKline

Ilker Yalcin, Eli Lilly